SOD1 and supranuclear palsy, progressive, 1: Figures 6a and b show that the CSF samples of the ALS cases contained significantly higher apparent amounts of SOD1 reactive to apoSOD and EDI antibodies than those of the non-ND and the other neurodegenerative disease cases (PD, DLB, PSP, and AD).